Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study
- PMID: 27354249
- PMCID: PMC4926251
- DOI: 10.1038/srep29024
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study
Abstract
Lactobacillus species dominate the vaginal microbiota of healthy reproductive-age women and protect the genitourinary tract from the attack of several infectious agents. Chlamydia trachomatis, a leading cause of sexually transmitted disease worldwide, can induce severe sequelae, i.e. pelvic inflammatory disease, infertility and ectopic pregnancy. In the present study we investigated the interference of Lactobacillus crispatus, L. gasseri and L. vaginalis, known to be dominant species in the vaginal microbiome, with the infection process of C. trachomatis. Lactobacilli exerted a strong inhibitory effect on Chlamydia infectivity mainly through the action of secreted metabolites in a concentration/pH dependent mode. Short contact times were the most effective in the inhibition, suggesting a protective role of lactobacilli in the early steps of Chlamydia infection. The best anti-Chlamydia profile was shown by L. crispatus species. In order to delineate metabolic profiles related to anti-Chlamydia activity, Lactobacillus supernatants were analysed by (1)H-NMR. Production of lactate and acidification of the vaginal environment seemed to be crucial for the activity, in addition to the consumption of the carbonate source represented by glucose. The main conclusion of this study is that high concentrations of L. crispatus inhibit infectivity of C. trachomatis in vitro.
Figures





Similar articles
-
Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2.PLoS One. 2014 Sep 12;9(9):e107758. doi: 10.1371/journal.pone.0107758. eCollection 2014. PLoS One. 2014. PMID: 25215504 Free PMC article.
-
Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro.Int J Med Microbiol. 2015 Dec;305(8):815-27. doi: 10.1016/j.ijmm.2015.07.005. Epub 2015 Sep 5. Int J Med Microbiol. 2015. PMID: 26372530
-
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells.Front Microbiol. 2018 Nov 6;9:2630. doi: 10.3389/fmicb.2018.02630. eCollection 2018. Front Microbiol. 2018. PMID: 30459737 Free PMC article.
-
Lactobacillus crispatus as biomarker of the healthy vaginal tract.Ann Biol Clin (Paris). 2016 Aug 1;74(4):421-7. doi: 10.1684/abc.2016.1169. Ann Biol Clin (Paris). 2016. PMID: 27492695 Review. English.
-
Alterations of Vaginal Microbiota and Chlamydia trachomatis as Crucial Co-Causative Factors in Cervical Cancer Genesis Procured by HPV.Microorganisms. 2023 Mar 6;11(3):662. doi: 10.3390/microorganisms11030662. Microorganisms. 2023. PMID: 36985236 Free PMC article. Review.
Cited by
-
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies.Microorganisms. 2021 Apr 30;9(5):975. doi: 10.3390/microorganisms9050975. Microorganisms. 2021. PMID: 33946391 Free PMC article.
-
Role of the human vaginal microbiota in the regulation of inflammation and sexually transmitted infection acquisition: Contribution of the non-human primate model to a better understanding?Front Reprod Health. 2022 Dec 6;4:992176. doi: 10.3389/frph.2022.992176. eCollection 2022. Front Reprod Health. 2022. PMID: 36560972 Free PMC article. Review.
-
The implausible "in vivo" role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota.Microbiome. 2018 Feb 6;6(1):29. doi: 10.1186/s40168-018-0418-3. Microbiome. 2018. PMID: 29409534 Free PMC article.
-
Microbiota composition of the koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease.Sci Rep. 2017 Jul 12;7(1):5239. doi: 10.1038/s41598-017-05454-2. Sci Rep. 2017. PMID: 28701755 Free PMC article.
-
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.Nat Commun. 2019 Dec 11;10(1):5656. doi: 10.1038/s41467-019-13468-9. Nat Commun. 2019. PMID: 31827089 Free PMC article.
References
-
- Larsen B. & Monif G. R. Understanding the bacterial flora of the female genital tract. Clin. Infect. Dis. 32, e69–77 (2001). - PubMed
-
- Gupta K. et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J. Infect. Dis. 178, 446–450 (1998). - PubMed
-
- Pybus V. & Onderdonk A. B. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect. 1, 285–292 (1999). - PubMed
-
- Cherpes T. L., Meyn L. A., Krohn M. A., Lurie J. G. & Hillier S. L. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37, 319–325 (2003). - PubMed
-
- Martin H. L. et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863–1868 (1999). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources